These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 27649293)

  • 1. Trends and Outcomes of Patent Ductus Arteriosus Treatment in Very Preterm Infants in Canada.
    Lokku A; Mirea L; Lee SK; Shah PS;
    Am J Perinatol; 2017 Apr; 34(5):441-450. PubMed ID: 27649293
    [No Abstract]   [Full Text] [Related]  

  • 2. Patent ductus arteriosus management and outcomes in Japan and Canada: comparison of proactive and selective approaches.
    Isayama T; Mirea L; Mori R; Kusuda S; Fujimura M; Lee SK; Shah PS;
    Am J Perinatol; 2015 Sep; 32(11):1087-94. PubMed ID: 25825965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of patent ductus arteriosus and neonatal mortality/morbidities: adjustment for treatment selection bias.
    Mirea L; Sankaran K; Seshia M; Ohlsson A; Allen AC; Aziz K; Lee SK; Shah PS;
    J Pediatr; 2012 Oct; 161(4):689-94.e1. PubMed ID: 22703954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal Intensive Care Unit-Level Patent Ductus Arteriosus Treatment Rates and Outcomes in Infants Born Extremely Preterm.
    Isayama T; Kusuda S; Reichman B; Lee SK; Lehtonen L; Norman M; Adams M; Bassler D; Helenius K; Hakansson S; Yang J; Jain A; Shah PS;
    J Pediatr; 2020 May; 220():34-39.e5. PubMed ID: 32145968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Patent Ductus Arteriosus Ligation With Death or Neurodevelopmental Impairment Among Extremely Preterm Infants.
    Weisz DE; Mirea L; Rosenberg E; Jang M; Ly L; Church PT; Kelly E; Kim SJ; Jain A; McNamara PJ; Shah PS
    JAMA Pediatr; 2017 May; 171(5):443-449. PubMed ID: 28264088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patent Ductus Arteriosus and the Effects of Its Late Closure in Preterm Infants with Severe Bronchopulmonary Dysplasia.
    Ansems SM; Kirpalani H; Mercer-Rosa L; Wang Y; Hopper RK; Fraga MV; Jensen EA
    Neonatology; 2019; 116(3):236-243. PubMed ID: 31269508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covariation of Neonatal Intensive Care Unit-Level Patent Ductus Arteriosus Management and In-Neonatal Intensive Care Unit Outcomes Following Preterm Birth.
    Hagadorn JI; Bennett MV; Brownell EA; Payton KSE; Benitz WE; Lee HC
    J Pediatr; 2018 Dec; 203():225-233.e1. PubMed ID: 30243544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes.
    Liebowitz M; Clyman RI
    J Pediatr; 2017 Aug; 187():119-126.e1. PubMed ID: 28396025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012.
    Stoll BJ; Hansen NI; Bell EF; Walsh MC; Carlo WA; Shankaran S; Laptook AR; Sánchez PJ; Van Meurs KP; Wyckoff M; Das A; Hale EC; Ball MB; Newman NS; Schibler K; Poindexter BB; Kennedy KA; Cotten CM; Watterberg KL; D'Angio CT; DeMauro SB; Truog WE; Devaskar U; Higgins RD;
    JAMA; 2015 Sep; 314(10):1039-51. PubMed ID: 26348753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of therapeutic approach on the neonatal evolution of very low birth weight infants with patent ductus arteriosus.
    Sadeck LS; Leone CR; Procianoy RS; Guinsburg R; Marba ST; Martinez FE; Rugolo LM; Moreira ME; Fiori RM; Ferrari LL; Menezes JA; Venzon PS; Abdallah VQ; Duarte JL; Nunes MV; Anchieta LM; Alves Filho N
    J Pediatr (Rio J); 2014; 90(6):616-23. PubMed ID: 25046256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morbidities associated with patent ductus arteriosus in preterm infants. Nationwide cohort study.
    Härkin P; Marttila R; Pokka T; Saarela T; Hallman M
    J Matern Fetal Neonatal Med; 2018 Oct; 31(19):2576-2583. PubMed ID: 28651469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Milrinone on Neonates after Patent Ductus Arteriosus Ligation: A Retrospective Nationwide Database Study.
    Kitaoka H; Konishi T; Shitara Y; Ito A; Kashima K; Fujita A; Matsui H; Kato M; Takahashi N; Yasunaga H
    Neonatology; 2023; 120(6):751-759. PubMed ID: 37757762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of practice change on outcomes of extremely preterm infants with patent ductus arteriosus.
    Ezenwa B; Pena E; Schlegel A; Bapat R; Shepherd EG; Nelin LD
    Acta Paediatr; 2019 Jan; 108(1):88-93. PubMed ID: 29806710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Short-term outcomes and their related risk factors of extremely preterm and extremely low birth weight infants in Guangdong province].
    Collaborative Study Group for Extremely Preterm and Extremely Low Birth Weight Infants
    Zhonghua Er Ke Za Zhi; 2019 Dec; 57(12):934-942. PubMed ID: 31795560
    [No Abstract]   [Full Text] [Related]  

  • 15. Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial).
    Hundscheid T; Onland W; van Overmeire B; Dijk P; van Kaam AHLC; Dijkman KP; Kooi EMW; Villamor E; Kroon AA; Visser R; Vijlbrief DC; de Tollenaer SM; Cools F; van Laere D; Johansson AB; Hocq C; Zecic A; Adang E; Donders R; de Vries W; van Heijst AFJ; de Boode WP
    BMC Pediatr; 2018 Aug; 18(1):262. PubMed ID: 30077184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Mortality and In-Hospital Outcomes of Preterm Infants Treated with Ibuprofen for Patent Ductus Arteriosus with or without Clinical Symptoms Attributable to the Patent Ductus Arteriosus at the Time of Ibuprofen Treatment.
    Yoo H; Lee JA; Oh S; Jung YH; Sohn JA; Shin SH; Choi CW; Kim EK; Kim HS; Kim BI
    J Korean Med Sci; 2017 Jan; 32(1):115-123. PubMed ID: 27914140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants.
    ElHassan NO; Bird TM; King AJ; Ambadwar PB; Jaquiss RD; Kaiser JR; Robbins JM
    J Neonatal Perinatal Med; 2014 Jan; 7(3):229-35. PubMed ID: 25322995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged persistent patent ductus arteriosus: potential perdurable anomalies in premature infants.
    Saldeño YP; Favareto V; Mirpuri J
    J Perinatol; 2012 Dec; 32(12):953-8. PubMed ID: 22460543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of patent ductus arteriosus ligation in premature infants in the East of England: a prospective cohort study.
    Kang SL; Samsudin S; Kuruvilla M; Dhelaria A; Kent S; Kelsall WA
    Cardiol Young; 2013 Oct; 23(5):711-6. PubMed ID: 23164413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of early caffeine administration and neonatal outcomes in very preterm neonates.
    Lodha A; Seshia M; McMillan DD; Barrington K; Yang J; Lee SK; Shah PS;
    JAMA Pediatr; 2015 Jan; 169(1):33-8. PubMed ID: 25402629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.